KOR
ENG
About us
Our Company
Founder’s Message
History
Members
Our Science
Platform
Pipelines
Disease Areas
Publications
Media
Company News
Contact us
Contact Us
KOR
ENG
Media
Company News
Company News
(2022-11-11) Aimedbio scores second 'KDDF' grant with its immune therapeutics targeting tumor-associated macrophages
2023.02.28
(2022-09-13) Aimedbio joins ‘Lee Kun-hee’s support for children with cancers and rare diseases’ with its precision medicine platform AVATASCAN®
2023.02.28
(2022-07-29) Aimedbio and GCcell collaborates on the next generation CAR-NK cell therapy development
2023.02.28
(2022-07-27) Parkinson's treatment strategies and cell therapy research results shared at Aimedbio's 2nd Parkinson's Disease salon
2023.02.28
(2022-05-17) Aimedbio develops antibodies with novel targets based on ‘patient big data’
2023.02.28
(2022-04-19) GeneQuantum and AIMEDBIO collaborate on a First-In-Class Antibody -Drug-Conjugate
2023.02.28
(2021-11-05) Aimedbio’s possible first-in-class brain tumor therapeutics selected by the KDDF
2023.02.28
1
Contact Us >>